Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications.
Bartolini C, Roberto G, Girardi A, Moscatelli V, Spini A, Barchielli A, Bocchia M, Fabbri A, Donnini S, Ziche M, Monti MC, Gini R. Bartolini C, et al. Among authors: gini r. Front Oncol. 2023 May 31;13:1059109. doi: 10.3389/fonc.2023.1059109. eCollection 2023. Front Oncol. 2023. PMID: 37324023 Free PMC article.
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Convertino I, Cazzato M, Tillati S, Giometto S, Gini R, Valdiserra G, Cappello E, Ferraro S, Bonaso M, Bartolini C, Paoletti O, Lorenzoni V, Trieste L, Filippi M, Turchetti G, Cristofano M, Blandizzi C, Mosca M, Lucenteforte E, Tuccori M. Convertino I, et al. Among authors: gini r. Front Pharmacol. 2023 Sep 25;14:1244486. doi: 10.3389/fphar.2023.1244486. eCollection 2023. Front Pharmacol. 2023. PMID: 37818193 Free PMC article.
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project.
Trifirò G, Isgrò V, Ingrasciotta Y, Ientile V, L'Abbate L, Foti SS, Belleudi V, Poggi F, Fontana A, Moretti U, Lora R, Sabaini A, Senesi I, Sorrentino C, Puzo MR, Padula A, Fusco M, Giordana R, Solfrini V, Puccini A, Rossi P, Del Zotto S, Leoni O, Zanforlini M, Ancona D, Bavaro V, Garau D, Ledda S, Scondotto S, Allotta A, Tuccori M, Gini R, Bucaneve G, Franchini D, Cavazzana A, Biasi V, Spila Alegiani S, Massari M; VALORE Project Collaborators. Trifirò G, et al. Among authors: gini r. BioDrugs. 2021 Nov;35(6):749-764. doi: 10.1007/s40259-021-00498-3. Epub 2021 Oct 12. BioDrugs. 2021. PMID: 34637126 Free PMC article.
NAVIGATOR: an Italian regional imaging biobank to promote precision medicine for oncologic patients.
Borgheresi R, Barucci A, Colantonio S, Aghakhanyan G, Assante M, Bertelli E, Carlini E, Carpi R, Caudai C, Cavallero D, Cioni D, Cirillo R, Colcelli V, Dell'Amico A, Di Gangi D, Erba PA, Faggioni L, Falaschi Z, Gabelloni M, Gini R, Lelii L, Liò P, Lorito A, Lucarini S, Manghi P, Mangiacrapa F, Marzi C, Mazzei MA, Mercatelli L, Mirabile A, Mungai F, Miele V, Olmastroni M, Pagano P, Paiar F, Panichi G, Pascali MA, Pasquinelli F, Shortrede JE, Tumminello L, Volterrani L, Neri E; NAVIGATOR Consortium Group. Borgheresi R, et al. Among authors: gini r. Eur Radiol Exp. 2022 Nov 8;6(1):53. doi: 10.1186/s41747-022-00306-9. Eur Radiol Exp. 2022. PMID: 36344838 Free PMC article.
Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review.
Gini R, Pajouheshnia R, Gardarsdottir H, Bennett D, Li L, Gulea C, Wientzek-Fleischmann A, Bazelier MT, Burcu M, Dodd C, Durán CE, Kaplan S, Lanes S, Marinier K, Roberto G, Soman K, Zhou X, Platt R, Setoguchi S, Hall GC. Gini R, et al. Pharmacoepidemiol Drug Saf. 2024 May;33(5):e5787. doi: 10.1002/pds.5787. Pharmacoepidemiol Drug Saf. 2024. PMID: 38724471 Review.
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases.
Schultze A, Martin I, Messina D, Bots S, Belitser S, José Carreras-Martínez J, Correcher-Martinez E, Urchueguía-Fornes A, Martín-Pérez M, García-Poza P, Villalobos F, Pallejà-Millán M, Alberto Bissacco C, Segundo E, Souverein P, Riefolo F, Durán CE, Gini R, Sturkenboom M, Klungel O, Douglas I. Schultze A, et al. Among authors: gini r. Vaccine. 2024 Apr 30;42(12):3039-3048. doi: 10.1016/j.vaccine.2024.03.043. Epub 2024 Apr 5. Vaccine. 2024. PMID: 38580517 Free article.
COVID-19 and pregnancy: A European study on pre- and post-infection medication use.
Hurley E, Geisler BP, Lupattelli A, Poblador-Plou B, Lassalle R, Jové J, Bernard MA, Sakr D, Sanfélix-Gimeno G, Sánchez-Saez F, Rodríguez-Bernal CL, Sabaté M, Ballarín E, Aguilera C, Jordan S, Thayer D, Farr I, Ahmed S, Bartolini C, Limoncella G, Paoletti O, Gini R, Maglanoc LA, Dudukina E, Ehrenstein V, Alsina E, Vaz TA, Riera-Arnau J, Sturkenboom MCJM, Nordeng HME. Hurley E, et al. Among authors: gini r. Eur J Clin Pharmacol. 2024 May;80(5):707-716. doi: 10.1007/s00228-024-03639-z. Epub 2024 Feb 12. Eur J Clin Pharmacol. 2024. PMID: 38347228 Free PMC article.
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project.
Ingrasciotta Y, Spini A, L'Abbate L, Fiore ES, Carollo M, Ientile V, Isgrò V, Cavazzana A, Biasi V, Rossi P, Ejlli L, Belleudi V, Poggi F, Sapigni E, Puccini A, Ancona D, Stella P, Pollina Addario S, Allotta A, Leoni O, Zanforlini M, Tuccori M, Gini R, Trifirò G. Ingrasciotta Y, et al. Among authors: gini r. Pharmacol Res. 2024 Feb;200:107074. doi: 10.1016/j.phrs.2024.107074. Epub 2024 Jan 15. Pharmacol Res. 2024. PMID: 38232909 Free article.
159 results